Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up

scientific article published in February 2013

Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.UROLOGY.2012.08.112
P698PubMed publication ID23374803

P2093author name stringRichard G Stock
Nelson N Stone
Michael Buckstein
Todd J Carpenter
P2860cites workComparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupQ27011661
Physician visits prior to treatment for clinically localized prostate cancer.Q34610617
Impact of age at diagnosis on prostate cancer treatment and survivalQ34679220
Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosisQ35184342
Treatment decision-making for localized prostate cancer: what younger men choose and why.Q36182162
Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.Q45032576
Prevalence and risk factors for erectile dysfunction in the US.Q45225557
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancerQ48374059
Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer.Q48607920
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.Q51961427
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.Q53242116
Quality of life and satisfaction with outcome among prostate-cancer survivorsQ80917895
Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostateQ83437107
Long-term potency preservation following brachytherapy for prostate cancerQ84461485
10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patientsQ84626494
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 yearsQ94515819
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectadenocarcinomaQ356033
brachytherapyQ896687
prostate adenocarcinomaQ18555107
P304page(s)364-368
P577publication date2013-02-01
P1433published inUrologyQ7900884
P1476titleLong-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up
P478volume81

Reverse relations

cites work (P2860)
Q38356515A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment
Q36276830Comparison of permanent (125)I seeds implants with two different techniques in 500 cases of prostate cancer
Q48543708Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials
Q95503798Editorial comment
Q35174871Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Q30395537In vivo visualization of prostate brachytherapy seeds with photoacoustic imaging
Q35005250Iodine-125 induces apoptosis via regulating p53, microvessel density, and vascular endothelial growth factor in colorectal cancer
Q41478724Long term outcome and side effects in patients receiving low-dose I125 brachytherapy: a retrospective analysis
Q48187737Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer
Q47209706Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer
Q49177979Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series
Q30746543Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique
Q43888431Urinary Incontinence Following Prostate Brachytherapy